Company detailsCompany name: ArkopharmaCompany country: FranceSector: C - ManufacturingSector detail: C21 - Manufacture of basic pharmaceutical products and pharmaceutical preparationsSub-sectors: C21.2.0 - Manufacture of pharmaceutical preparations Reshoring detailsReshoring announcement date: 10/04/2017Starting implementation date: January, 2017Reshored to: FranceLocation of affected unit(s): CarrosLocation code: FRL0Reshored business function: ProductionPartial or Total reshoring: TotalReshoring governance mode: In house (in own facilities)Reasons for reshoring: "Made in" effectFirm's global reorganizationR&D vicinityUntapped production capacityCase narrative: Arkopharma is a French pharmaceutical company founded in 1980 manufacturing phytotherapeutic and natural drugs and food integrators. In 2017, the company decided to to close its manufacturing sites in Italy and Ireland and centralize the production activities in Carros (France). The company aimed to reduce its production over-capacity increasing its efficiency level. It also aimed to leverage on the made in effect. Huge investments were implemented also to improve the collaboration between the R&D and the production departments. Sources: Marie Claire Méditerranées 07/12/2017 Arkopharma news Sources link: https://leblogmcmd.fr/beaute/arkopharma-x-mcmd-lintelligence-des-plantes/ https://www.arkopharma.com/en-GB/guaranteed-made-in-france Offshoring detailsOffshoring location: IrelandOffshored business function: ProductionOffshoring governance mode: In house (in own facilities)Host country geographical area: Western Europe
